Life Tech, Gen-Probe to Collaborate on FDA Clearance for Dx Assays on CE Sequencer
May 24, 2011
Life Tech, Gen-Probe to Collaborate on FDA Clearance for Dx Assays on CE Sequencer
Under the agreement, Gen-Probe will commercialize future diagnostic tests — based on DNA sequencing or DNA fragment analysis — that will run on Life Tech's 3500 Dx Genetic Analyzer.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Life Tech Submits 3500 CE Machine and HLA Typing Kit for FDA 510(k) Approval
August 3, 2011 / Clinical Sequencing News - Life Tech Begins Clinical Trials of CE Sequencer for HLA Typing; Plans 510(k) Clearance
March 22, 2011 / Clinical Sequencing News - In Brief This Week: Life Technologies; SG Biofuels; Ambry Genetics; Wheat Genome; Gen-Probe; AnaSpec
August 27, 2010 / GenomeWeb Daily News - Gen-Probe Unit to Distribute LifeTech's SeCore HLA Typing Kits
July 24, 2012 / GenomeWeb Daily News - Life Tech Looks to Develop HLA Typing Assays for PGM
April 18, 2012 / Clinical Sequencing News